Talis Biomedical Corp (TLIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,218 | 257 | 796 | 572 | 3,187 |
| Cost of Goods | 20 | 2,332 | 1,236 | 1,302 | 3,521 |
| Gross Profit | 1,198 | -2,075 | -440 | -730 | -334 |
| Operating Expenses | 20,215 | 26,370 | 26,582 | 26,845 | 33,154 |
| Operating Income | -18,997 | -28,113 | -26,786 | -27,273 | -32,967 |
| Other Income | 1,166 | 1,184 | 765 | 262 | -84 |
| Pre-tax Income | -17,831 | -26,929 | -26,021 | -27,011 | -33,051 |
| Net Income Continuous | -17,831 | -26,929 | -26,021 | -27,011 | -33,051 |
| Net Income | $-17,831 | $-26,929 | $-26,021 | $-27,011 | $-33,051 |
| EPS Basic Total Ops | -9.84 | -14.58 | -14.44 | -15.01 | -18.74 |
| EPS Basic Continuous Ops | -9.84 | -14.59 | -14.45 | -15.01 | -18.72 |
| EPS Diluted Total Ops | -9.84 | -14.58 | -14.44 | -15.01 | -18.74 |
| EPS Diluted Continuous Ops | -9.84 | -14.59 | -14.45 | -15.01 | -18.72 |
| EPS Diluted Before Non-Recurring Items | -9.90 | -14.99 | -14.69 | N/A | N/A |
| EBITDA(a) | $-18,823 | $-24,551 | $-22,861 | $-26,293 | $-32,604 |